PMID: 18729018Aug 30, 2008Paper

Small-molecule inhibitors of protein-protein interactions

Current Opinion in Drug Discovery & Development
Thorsten Berg

Abstract

Protein-protein interactions regulate almost all aspects of cellular signaling and aberrant protein-protein interactions have the potential to cause or contribute to human disease. The modulation of these interactions by drug-like molecules would offer previously unavailable opportunities to explore the relevance of pre-selected protein-protein interactions for cellular signaling, as well as benefits to patients. After an initial period of skepticism with regards to feasibility, there is now an encouraging set of data indicating that the effective and selective modulation of protein-protein interactions by drug-like molecules is attainable. This review highlights selected areas of current research that are aimed at identifying potent inhibitors of disease-relevant protein-protein interactions.

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Related Papers

Mini Reviews in Medicinal Chemistry
Joseph M Hayes, Demetres D Leonidas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Kristiina IljinOlli Kallioniemi
CNS & Neurological Disorders Drug Targets
Adriana Sanchez-DanesAntonella Consiglio
Current Trends in Medicinal Chemistry
Marilyn M MatthewsAlexander D Mackerell
© 2022 Meta ULC. All rights reserved